Health ❯ Healthcare ❯ Patient Outcomes
Chronic Illness Management Adverse Events Pain Management Health Improvements Post-Transplant Recovery Fatigue Management Diabetes-Related Complications Long-term Treatment Efficacy Treatment Decisions Functional Recovery Migraine Disability Assessment Health-Related Quality of Life Disease Management Sleep Quality Long-term Follow-up Physical Health Patient Reported Outcomes Functional Improvement Treatment Efficacy Amputation Risk Clinical Endpoints Gait Velocity Improvement Pain Reduction Strategies Sleep Quality Improvements Postpartum Care Clinical Efficacy Cost-Effectiveness Symptom Management Physical Function Survivorship Clinical Global Impression Dietary Counseling Treatment Durability Long-term Treatment Options Long-term Recovery KCCQ-CSS Improvement Mobility Evaluation for Amputees
The company moves to raise $175 million following the readout, signaling plans for an FDA filing in the second half of 2026.
